Structures by: Baisch U.
Total: 62
N,N-dimethylaniline-N-naphthalimide
C20H16N2O2
Chem. Sci. (2015) 6, 6 3525
a=9.4336(8)Å b=9.5749(8)Å c=9.9183(9)Å
α=115.803(9)° β=97.324(7)° γ=104.839(7)°
N,N-dimethylaniline-N-naphthalimide
C20H16N2O2
Chem. Sci. (2015) 6, 6 3525
a=17.3700(9)Å b=29.0684(13)Å c=8.8805(4)Å
α=90° β=94.498(4)° γ=90°
((2R,3S,4R,5R,6S)-3,4-Dihydroxy-6-methoxy-5-(methylsulfonamido) tetrahydro-2H-pyran-2-yl)methyl sulfamate
C8H18N2O9S2
Organic & biomolecular chemistry (2015) 13, 18 5279-5284
a=7.9598(3)Å b=9.8111(3)Å c=17.7241(6)Å
α=90° β=90° γ=90°
2-(3-((6-Ethynyl-9-methyl-9H-purin-2-yl)amino)phenyl)acetamide
C16H14N6O
Organic & biomolecular chemistry (2014) 12, 1 141-148
a=20.838(4)Å b=4.7845(9)Å c=14.873(4)Å
α=90° β=105.57(2)° γ=90°
2-(3-((6-Ethynyl-7-methyl-7H-purin-2-yl)amino)phenyl)acetamide
C16H14N6O,0.5(CH4O)
Organic & biomolecular chemistry (2014) 12, 1 141-148
a=15.3730(7)Å b=14.1912(4)Å c=16.2612(7)Å
α=90° β=117.831(6)° γ=90°
1,4-diammonio-cyclohexane dichloride
C6H16N2,2(Cl)
CrystEngComm (2008) 10, 12 1939
a=5.25760(10)Å b=14.8849(3)Å c=6.35470(10)Å
α=90.00° β=99.850(2)° γ=90.00°
Dipiperazinium tetrachloride monohydrate
C4H12N2,0.5(H2O),2(Cl)
CrystEngComm (2008) 10, 12 1939
a=11.6011(11)Å b=9.6530(8)Å c=13.9669(12)Å
α=90.00° β=90.00° γ=90.00°
1-ammonio-2-amine-cyclohexane chloride
C6H15N2,Cl
CrystEngComm (2008) 10, 12 1939
a=7.4694(2)Å b=15.3118(3)Å c=8.0970(2)Å
α=90.00° β=110.144(3)° γ=90.00°
Piperazinium dichloride monohydrate
C4H12N2,H2O,2(Cl)
CrystEngComm (2008) 10, 12 1939
a=10.1916(3)Å b=6.3108(2)Å c=13.4929(4)Å
α=90.00° β=107.553(3)° γ=90.00°
1,2-diammonio-cyclohexane dichloride mono-sulfoxide
C6H16N2,2(C2H6OS),2(Cl)
CrystEngComm (2008) 10, 12 1939
a=5.8630(6)Å b=8.2478(9)Å c=9.5959(9)Å
α=89.659(8)° β=76.931(8)° γ=75.820(9)°
Hexamelaminium-nitrato-tetraoxalatoytterbate(III)-triaqua
C8O16Yb,6(C3H7N6),NO3,3.65(H2O)
CrystEngComm (2009) 11, 1 40
a=9.7297(2)Å b=10.5937(2)Å c=24.9904(3)Å
α=87.2710(10)° β=80.1230(10)° γ=86.9550(10)°
Potassium amino(ethanesulfonate)anthracene dihydrate
C18H20KNO4S,H2O
RSC Adv. (2016) 6, 5 3783
a=23.671(5)Å b=8.6038(19)Å c=9.530(2)Å
α=90° β=99.236(2)° γ=90°
Phenyl beta-aminobisulfonate
0.25(C40H68K8N4O32S8)
RSC Adv. (2016) 6, 88 84712
a=8.2498(3)Å b=22.5592(7)Å c=8.7439(3)Å
α=90° β=90° γ=90°
Phenyl beta-aminobisulfonate
C44H72Br0.12K9N4O37S8,0.88(Br1)
RSC Adv. (2016) 6, 88 84712
a=17.9837(3)Å b=13.1145(2)Å c=32.7662(6)Å
α=90° β=102.8278(19)° γ=90°
C13H16BKN8S
C13H16BKN8S
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4647-4659
a=16.7702(4)Å b=11.5282(3)Å c=18.6564(3)Å
α=90.00° β=90.00° γ=90.00°
C21H30BIrN6S2,C1H2Cl2
C21H30BIrN6S2,C1H2Cl2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4647-4659
a=15.2566(2)Å b=9.7542(2)Å c=17.7813(3)Å
α=90.00° β=93.7010(10)° γ=90.00°
C32H33BIrN6OPS2,2(CH2Cl2)
C32H33BIrN6OPS2,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4647-4659
a=11.7634(4)Å b=12.8390(5)Å c=14.8572(6)Å
α=85.9710(10)° β=72.1290(10)° γ=67.116(2)°
C30H29BIrN6OPS2,CH2Cl2
C30H29BIrN6OPS2,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4647-4659
a=9.55120(10)Å b=17.3810(2)Å c=20.3269(2)Å
α=90.00° β=90.00° γ=90.00°
C28H40BClIr2N6S3,2(CH2Cl2)
C28H40BClIr2N6S3,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4647-4659
a=10.8535(18)Å b=14.237(3)Å c=14.797(3)Å
α=113.731(7)° β=91.748(7)° γ=108.989(7)°
C14H22BKN6OS2
C14H22BKN6OS2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4647-4659
a=6.9487(14)Å b=37.295(8)Å c=14.782(3)Å
α=90.00° β=94.10(3)° γ=90.00°
C11H14BKN6S2,0.5(CH4O)
C11H14BKN6S2,0.5(CH4O)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4647-4659
a=10.8712(2)Å b=12.5318(3)Å c=13.7319(3)Å
α=113.484(1)° β=100.682(1)° γ=94.266(1)°
C15H18BIrN6O2S2,CH2Cl2
C15H18BIrN6O2S2,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 17 4647-4659
a=8.8351(2)Å b=10.3766(2)Å c=13.2958(4)Å
α=73.239(1)° β=84.423(1)° γ=85.728(1)°
Cabazitaxel
C45H57NO14
CrystEngComm (2014) 16, 44 10161
a=8.351(3)Å b=44.438(17)Å c=11.410(4)Å
α=90° β=98.532(5)° γ=90°
Cabazitaxel tetrahydrofurane solvate
C45H57NO14,0.5(C7H14.03O2)
CrystEngComm (2014) 16, 44 10161
a=11.778(5)Å b=17.208(7)Å c=12.339(5)Å
α=90° β=109.747(5)° γ=90°
Cabazitaxel Acetone Solvate
C45H57NO14,C3H6O
CrystEngComm (2014) 16, 44 10161
a=11.725(2)Å b=17.328(3)Å c=12.449(2)Å
α=90° β=110.453(2)° γ=90°
Cabazitaxel hemihydrate
C45H57NO14,0.25(H2O)
CrystEngComm (2014) 16, 44 10161
a=8.506(5)Å b=45.16(2)Å c=11.675(6)Å
α=90° β=98.362(4)° γ=90°
Cabazitaxel ethanol solvate hemihydrate
C45H57NO14,C2H5O,0.5(H2O)
CrystEngComm (2014) 16, 44 10161
a=12.542(2)Å b=8.6716(16)Å c=42.090(8)Å
α=90° β=89.987(2)° γ=90°
Bis-1,2,3-Triamino-2,4,6-triazinium ethylenetriaminetetraacetate diaqua
C10H14N2O8,2(C3H7N6),2(H2O)
CrystEngComm (2014) 16, 35 8147
a=7.0884(3)Å b=7.7150(2)Å c=11.6340(5)Å
α=80.755(3)° β=78.037(4)° γ=83.455(3)°
Melamine DMSO solvate
C3H6N6,C2H6OS
CrystEngComm (2014) 16, 35 8147
a=7.4296(6)Å b=12.3333(11)Å c=11.9384(11)Å
α=90° β=114.070(6)° γ=90°
Dimelaminium sulfate
2(C3H7N6),O4S
CrystEngComm (2014) 16, 35 8147
a=18.041(2)Å b=10.6373(14)Å c=14.289(2)Å
α=90° β=103.652(14)° γ=90°
Melaminium dinitrate
C3H8N6,2(NO3)
CrystEngComm (2014) 16, 35 8147
a=7.7710(14)Å b=9.8924(18)Å c=12.186(2)Å
α=90° β=101.198(9)° γ=90°
Tri-theobromine melamine
C3H6N6,3(C7H8N4O2)
CrystEngComm (2014) 16, 35 8147
a=14.3308(8)Å b=16.2228(10)Å c=13.1104(10)Å
α=90° β=109.388(7)° γ=90°
Dimelaminium sulfate
2(C3H7N6),O4S
CrystEngComm (2014) 16, 35 8147
a=18.041(2)Å b=10.6373(14)Å c=14.289(2)Å
α=90° β=103.652(14)° γ=90°
Melaminium dinitrate
C3H8N6,2(NO3)
CrystEngComm (2014) 16, 35 8147
a=7.7710(14)Å b=9.8924(18)Å c=12.186(2)Å
α=90° β=101.198(9)° γ=90°
Tri-theobromine melamine
C3H6N6,3(C7H8N4O2)
CrystEngComm (2014) 16, 35 8147
a=14.3308(8)Å b=16.2228(10)Å c=13.1104(10)Å
α=90° β=109.388(7)° γ=90°
Bis-1,2,3-Triamino-2,4,6-triazinium ethylenetriaminetetraacetate diaqua
C10H14N2O8,2(C3H7N6),2(H2O)
CrystEngComm (2014) 16, 35 8147
a=7.0884(3)Å b=7.7150(2)Å c=11.6340(5)Å
α=80.755(3)° β=78.037(4)° γ=83.455(3)°
Melamine DMSO solvate
C3H6N6,C2H6OS
CrystEngComm (2014) 16, 35 8147
a=7.4296(6)Å b=12.3333(11)Å c=11.9384(11)Å
α=90° β=114.070(6)° γ=90°
5-Methylsalicylaldehyde
C8H8O2
Acta Crystallographica Section E (2017) 73, 2 155-158
a=8.3676(17)Å b=13.088(3)Å c=6.4867(13)Å
α=90° β=106.30(3)° γ=90°
Gallic Acid Tris-Caffeine hexahydrate
C7H6O5,3(C8H10N4O2),6(H2O)
Acta Crystallographica Section E (2018) 74, 4 559-562
a=16.5434(3)Å b=6.79456(11)Å c=18.1390(4)Å
α=90° β=110.865(2)° γ=90°
Docetaxel trihydrate
C43H53NO14,3(H2O)
Crystal Growth & Design (2013) 13, 10 4402
a=8.6619(8)Å b=12.7429(9)Å c=39.838(4)Å
α=90° β=90° γ=90°
Docetaxel monohydrate
C43H53NO14,H2O
Crystal Growth & Design (2013) 13, 10 4402
a=8.625(2)Å b=12.910(2)Å c=39.764(11)Å
α=90° β=90° γ=90°
Docetaxel monohydrate
C43H53NO14
Crystal Growth & Design (2013) 13, 10 4402
a=8.6078(8)Å b=12.9231(16)Å c=38.421(5)Å
α=90° β=90° γ=90°
Docetaxel hydrate ethanol solvate
C43H53NO14,C2H7O2
Crystal Growth & Design (2013) 13, 10 4402
a=12.608(3)Å b=8.6626(19)Å c=20.353(4)Å
α=90° β=98.942(2)° γ=90°
Docetaxel trihydrate
C43H53NO14,3(H2O)
Crystal Growth & Design (2013) 13, 10 4402
a=8.594(2)Å b=12.644(3)Å c=39.717(10)Å
α=90° β=90° γ=90°
Docetaxel dihydrate
C43H53NO14,CH3.5O,H2O
Crystal Growth & Design (2013) 13, 10 4402
a=10.287(2)Å b=32.938(8)Å c=12.780(3)Å
α=90° β=90.213(3)° γ=90°
C28H34CrN2
C28H34CrN2
Organometallics (2010) 29, 1 167
a=16.4341(19)Å b=9.3651(11)Å c=16.498(2)Å
α=90.00° β=101.508(4)° γ=90.00°
C30H38CrN2
C30H38CrN2
Organometallics (2010) 29, 1 167
a=12.2845(18)Å b=12.093(2)Å c=18.858(3)Å
α=90.00° β=108.328(7)° γ=90.00°
C33H37CrN2O3S
C33H37CrN2O3S
Organometallics (2010) 29, 1 167
a=9.6900(14)Å b=25.615(3)Å c=11.5530(14)Å
α=90.00° β=90.744(6)° γ=90.00°
C29H37ClCrN2
C29H37ClCrN2
Organometallics (2010) 29, 1 167
a=13.1109(3)Å b=15.2995(3)Å c=14.4144(3)Å
α=90.00° β=112.8180(10)° γ=90.00°
C31H41CrN2
C31H41CrN2
Organometallics (2010) 29, 1 167
a=14.1980(4)Å b=13.7783(5)Å c=28.1736(13)Å
α=90.00° β=90.00° γ=90.00°
C28H33CrN2O2
C28H33CrN2O2
Organometallics (2010) 29, 1 167
a=8.2143(12)Å b=13.597(2)Å c=22.030(3)Å
α=90.00° β=90.978(6)° γ=90.00°
C20H42B2P2
C20H42B2P2
Organometallics (2013) 33, 1 378
a=13.4679(6)Å b=12.2233(4)Å c=15.1681(7)Å
α=90° β=110.407(5)° γ=90°
C29H64B2KN3P2
C29H64B2KN3P2
Organometallics (2013) 33, 1 378
a=16.4751(10)Å b=11.6808(5)Å c=19.7554(9)Å
α=90° β=110.357(6)° γ=90°
C32H72B2Li2N4P2
C32H72B2Li2N4P2
Organometallics (2013) 33, 1 378
a=12.0666(9)Å b=17.2892(15)Å c=18.9818(14)Å
α=90° β=93.807(6)° γ=90°
C44H88B2Li2N4P2,2(C7H8)
C44H88B2Li2N4P2,2(C7H8)
Organometallics (2013) 33, 1 378
a=12.1193(5)Å b=17.3072(5)Å c=15.3776(7)Å
α=90° β=112.794(5)° γ=90°
C48H76B2Li2O4P2Si2
C48H76B2Li2O4P2Si2
Organometallics (2013) 33, 1 378
a=10.3857(6)Å b=10.5580(6)Å c=13.2588(8)Å
α=94.780(5)° β=104.055(5)° γ=112.142(5)°
2(C44H64B2Li2N4P2),2(C2.5O0.5)
2(C44H64B2Li2N4P2),2(C2.5O0.5)
Organometallics (2013) 33, 1 378
a=21.2669(6)Å b=16.6747(5)Å c=14.4678(4)Å
α=90° β=97.244(3)° γ=90°
C50H90B2K2N6P2Si2
C50H90B2K2N6P2Si2
Organometallics (2013) 33, 1 378
a=23.4801(12)Å b=48.364(4)Å c=10.4193(5)Å
α=90° β=90° γ=90°
C50H102B2K2N6P2
C50H102B2K2N6P2
Organometallics (2013) 33, 1 378
a=18.8732(6)Å b=21.7626(7)Å c=14.3884(4)Å
α=90° β=92.401(3)° γ=90°
Ceriumocene
C15H15Ce1
Organometallics (2006) 25, 12 3027
a=15.101(3)Å b=9.6683(19)Å c=16.621(3)Å
α=90.00° β=93.10(3)° γ=90.00°
Ceriumocene
C15H15Ce1
Organometallics (2006) 25, 12 3027
a=15.121(3)Å b=9.6696(19)Å c=16.593(3)Å
α=90.00° β=93.04(3)° γ=90.00°
Holmiumocene
C15H15Ho1
Organometallics (2006) 25, 12 3027
a=8.4303(17)Å b=14.085(3)Å c=19.407(4)Å
α=90.00° β=90.02(3)° γ=90.00°